Asymptomatic clients who are HIV-positive are at risk for developing cryptococcal meningitis. The Cryptococcal antigen test (CrAg) is a laboratory test that can detect the presence of Cryptococcus neoformans, the fungus that causes cryptococcal meningitis, in the blood or cerebrospinal fluid.

Pre-emptive fluconazole treatment is recommended for asymptomatic HIV-positive individuals who test positive for CrAg, as it can help prevent the development of cryptococcal meningitis. Therefore, performing a Cryptococcal antigen test (CrAg) is essential in identifying asymptomatic clients who may benefit from pre-emptive fluconazole treatment.

Diphtheria is a bacterial infection caused by Corynebacterium diphtheriae. It is characterized by the formation of grey membranes on the mucous membranes of the throat and tonsils, which can cause difficulty breathing (dyspnoea). This patient’s recent travel to India is significant because diphtheria is more common in developing countries, including India.

In contrast, infectious mononucleosis (also known as mono) is caused by the Epstein-Barr virus and typically presents with symptoms such as fever, sore throat, and swollen lymph nodes. Acute follicular tonsillitis is an infection of the tonsils usually caused by bacteria such as Streptococcus pyogenes. Scarlet fever is a bacterial infection caused by Streptococcus pyogenes that presents with a characteristic rash.

Agranulocytosis is a condition characterized by a severe decrease in the number of white blood cells, which can lead to increased susceptibility to infections. However, the presence of grey membranes on the uvula and tonsils is not a typical finding in agranulocytosis.

Therefore, based on the patient’s symptoms and recent travel history to India, the most likely diagnosis is diphtheria. It is important to confirm the diagnosis with laboratory tests and start appropriate treatment, which may include antibiotics and antitoxin therapy.

The guideline proposes using specific documents such as the Maternity Case Record for the mother and The Road to Health Booklet for the HIV-exposed infant because these documents are designed to capture all the necessary information related to the healthcare of HIV-positive women and their infants. These documents provide a structured format for recording important medical history, test results, treatment plans, and follow-up care. By using these specific documents, healthcare providers can ensure that all relevant information is documented accurately and consistently, which is essential for providing comprehensive and coordinated care to HIV-positive women and their infants. Additionally, using standardized documents like the Maternity Case Record and The Road to Health Booklet can facilitate communication and information sharing among healthcare providers, ultimately improving the quality of care for this vulnerable population.

Antibiotic resistance can occur through various mechanisms, including the inactivation of the drug by enzymes produced by the bacteria. These enzymes can modify or degrade the antibiotic, rendering it ineffective in killing the bacteria.

Transduction is a process where naked DNA is transferred from one bacterium to another through a virus, potentially transferring resistance genes along with it.

Active expulsion of the drug by nuclear efflux systems is another way bacteria can develop resistance. These efflux pumps can pump out the antibiotic before it can have an effect on the bacteria.

Transformation is a process where bacteria can acquire resistance genes from their environment, such as from other bacteria. This transfer of resistance genes can lead to the development of antibiotic resistance in the bacteria.

Therefore, the correct answer is: By enzymes which inactivate the drug, By transduction when naked DNA is incorporated by the host DNA, By active expulsion of drug by nuclear efflux systems, and By transformation when resistance is transferred from 1 bacteria to another.

When a patient on antiretroviral therapy (ART) has an unsuppressed viral load (VL ≥ 50 c/ml) despite having good adherence (over 80%), it is important to first address any potential adherence issues before considering a change in the treatment regimen. Adherence to ART medication is crucial for achieving and maintaining viral suppression, and even small lapses in adherence can lead to treatment failure.

By focusing on improving adherence through counseling, education, and support, healthcare providers can help the patient better understand the importance of taking their medication consistently and as prescribed. This may involve identifying and addressing any barriers to adherence, such as side effects, pill burden, or lifestyle factors.

Once adherence has been optimized, the patient’s viral load should be monitored closely to determine if viral suppression can be achieved without changing the current regimen. If adherence interventions are successful and the viral load remains unsuppressed, then a change in the ART regimen may be necessary.

In summary, the recommended action for a patient on ART with an unsuppressed viral load and good adherence is to focus on improving adherence before considering any changes to the treatment regimen. This approach allows for the potential for viral suppression to be achieved without unnecessary changes to the patient’s medication.

The most probable diagnosis in this case is HSV1, also known as herpes simplex virus type 1. This is because the patient presented with blisters on the tongue that secreted pinkish fluid, which is characteristic of HSV-1 infection. Additionally, the presence of crusted blisters is also a common feature of HSV-1 infection.

The other options provided (Chicken pox, Rubella, Measles, Erythema Infectiosum) do not typically present with blisters on the tongue as the primary symptom. Chicken pox, Rubella, and Measles are viral infections that present with a rash rather than blisters on the tongue. Erythema Infectiosum, also known as fifth disease, presents with a rash on the face that resembles a slapped cheek, but does not typically involve blisters on the tongue.

Therefore, based on the presentation of blisters on the tongue that secrete pinkish fluid and later crust over, the most likely diagnosis is HSV1.

The essential part of the baseline assessment for an infant diagnosed with HIV is a clinical review and blood tests, including a confirmatory HIV PCR. This is important to confirm the diagnosis of HIV in the infant and to determine the viral load and CD4 count, which are important indicators of the progression of the disease and the need for treatment. Additionally, an HIV drug resistance test may be necessary, especially if the mother is failing treatment on a specific regimen. This comprehensive assessment helps healthcare providers to develop an appropriate treatment plan and monitor the infant’s health and response to treatment over time. Other assessments such as dental examination, hearing test, eye examination, and skin sensitivity test may also be important for the overall health and well-being of the infant, but the clinical review and blood tests are crucial for managing HIV in the infant.

During pregnancy and breastfeeding, it is important for women living with HIV to continue taking antiretroviral therapy (ART) to prevent transmission of the virus to their baby. In addition to viral load monitoring, which measures the amount of HIV in the blood, CD4 count monitoring is also crucial. CD4 cells are a type of white blood cell that helps the immune system fight off infections. Monitoring CD4 counts can help healthcare providers assess the immune function of the mother and determine if the ART regimen is effectively controlling the virus.

Toxicity monitoring is also important for pregnant or breastfeeding women on ART. Some antiretroviral medications can have side effects that may be harmful to the mother or the developing baby. Regular monitoring for signs of toxicity, such as liver function tests, can help healthcare providers adjust the treatment regimen if necessary to minimize any potential risks.

In summary, pregnant or breastfeeding women on ART should undergo CD4 count and toxicity monitoring in addition to viral load monitoring to ensure the safety and effectiveness of their treatment.

Nevirapine (NVP) is an antiretroviral medication used to treat HIV/AIDS in infants. The dosing recommendation for infants aged birth to 6 weeks and weighing between 2.0 to 2.49 kg is 1 ml (10 mg) once daily. This dosage is based on the weight of the infant and is important to ensure the medication is effective and safe for the child.

The most likely diagnosis for this 34-year-old HIV positive man with jaundiced sclera and abnormal liver function tests is primary sclerosing cholangitis. This is because HIV can cause strictures in the biliary tract, leading to inflammation and scarring of the bile ducts. The elevated ALP and bilirubin levels, along with the presence of jaundiced sclera, are consistent with this diagnosis.

Sclerosing cholangitis is a chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to obstruction of bile flow. This can result in symptoms such as jaundice, fatigue, and itching. The liver function tests in this case show elevated ALP and bilirubin levels, which are indicative of cholestasis (impaired bile flow).

While other conditions such as hepatic abscess, fungal obstruction of the bile duct, duodenal adenoma, and primary biliary cirrhosis can also present with jaundice and abnormal liver function tests, the association of HIV with strictures in the biliary tract makes primary sclerosing cholangitis the most likely diagnosis in this case. It is important to consider the patient’s HIV status and the potential complications associated with the disease when making a diagnosis.

Human herpesvirus eight, also known as Kaposi’s sarcoma-associated herpesvirus (KSHV), is indeed sexually transmitted. This virus is associated with the development of Kaposi’s sarcoma, a cancer commonly occurring in AIDS patients, as well as other conditions such as primary effusion lymphoma and multicentric Castleman’s disease. Antibodies to HHV-8 are found in more than 50% of the general population, indicating widespread exposure to the virus. However, it is not associated with Burkitt’s lymphoma or myeloproliferative disorders. Therefore, the true statements regarding human herpesvirus eight are:
– It is sexually transmitted.
– Antibodies are found in more than 50% of the general population.

HIV is indeed an RNA virus. This means that its genetic material is composed of RNA, rather than DNA. The virus uses the enzyme reverse transcriptase to convert its RNA genome into DNA once it enters a host cell. This DNA is then integrated into the host cell’s genome, allowing the virus to replicate and spread.

The other statements provided in the question are incorrect. HIV is not a DNA virus, HIV 2 is not more pathogenic than HIV 1, HIV does not lead to depletion of B cells, and HIV enters cells using the CD4 receptor, not the CD3 receptor.

Although a variety of clinical specimens may be submitted to the laboratory to recover MTB and NTM, respiratory secretions such as sputum and bronchial aspirates are the most common. An early-morning specimen should be collected on three consecutive days, although recent studies have suggested that the addition of a third specimen does not significantly increase the sensitivity of detecting Mycobacteria.

Mycobacterium tuberculosis appear red on acid-fast staining because they take up the primary stain, which is carbolfuchsin, and is not decolorized by the acid alcohol anymore.

Culture on Lowenstein-Jensen medium should be read within 5 to 7 days after inoculation and once a week thereafter for up to 8 weeks.

Nucleic acid amplification assays designed to detect M. tuberculosis complex
bacilli directly from patient specimens can be performed in as little as 6 to 8 hours on processed specimens.

Bacteriostatic antibiotics work by inhibiting the growth or reproduction of bacteria, while bactericidal antibiotics work by directly killing bacteria. In this case, Penicillin is a bactericidal antibiotic because it inhibits cell wall synthesis, leading to bacterial cell death. Tetracycline, Erythromycin, and Sulphonamides are bacteriostatic antibiotics because they slow down bacterial growth or reproduction. Chloramphenicol is also primarily bacteriostatic, although it can exhibit bactericidal action in high concentrations. Therefore, the correct answer to the question is Penicillin.

Children under two years of age are at a higher risk of rapid disease progression if they are HIV-positive. Therefore, it is crucial to initiate antiretroviral therapy (ART) as soon as possible to prevent further complications and improve the child’s health outcomes. Waiting for confirmatory results before starting treatment can delay necessary care and potentially worsen the child’s condition. Additionally, providing cotrimoxazole prophylaxis can help prevent opportunistic infections in HIV-positive children. Confirming the HIV diagnosis with a rapid test can help ensure accurate results and guide appropriate treatment decisions. Overall, the priority should be to initiate ART promptly to give the child the best chance at a healthy life.

Breastfeeding is a critical component of infant nutrition and provides numerous health benefits for both the baby and the mother. However, for women with a newly diagnosed HIV infection or known HIV-positive status, there is a risk of transmitting the virus to their infants through breastfeeding.

In the context of feeding advice for these women, the recommended approach is exclusive breastfeeding (EBF) for the first six months of life. This recommendation is based on the fact that antiretroviral therapy (ART) significantly reduces the risk of postnatal HIV transmission during breastfeeding. By adhering to EBF guidelines, the risk of HIV transmission can be minimized while still providing the infant with the essential nutrients and antibodies found in breast milk.

It is important for healthcare workers to provide support and guidance to HIV-positive women on how to safely breastfeed their infants while minimizing the risk of transmission. Mixed feeding, which involves both breastfeeding and formula feeding, is not recommended as it can increase the risk of HIV transmission. Therefore, exclusive breastfeeding for the first six months of life is the best approach for HIV-positive women to ensure the health and well-being of both the mother and the infant.

Toxoplasmosis is a parasitic infection caused by the Toxoplasma gondii parasite. It can be transmitted through ingestion of contaminated food or water, handling cat litter, or from mother to fetus during pregnancy.

The correct statement regarding toxoplasmosis is that it can present with fits in patients with AIDS. This is because individuals with weakened immune systems, such as those with AIDS, are more susceptible to developing symptoms of toxoplasmosis, including seizures or fits.

Infection in the first trimester of pregnancy is actually very harmful to the fetus, as it can lead to serious complications such as intracranial calcifications, hydrocephalus, and blindness. Prophylactic immunoglobulins should be given to pregnant women if their IgM anti-toxoplasma antibodies are detected to help prevent transmission to the fetus.

Toxoplasmosis is usually acquired through ingestion of contaminated food or water, not through respiration. Raw eggs are not a common source of infection for toxoplasmosis, as it is typically associated with cat feces or raw/undercooked meat.

Overall, toxoplasmosis can have serious consequences, especially for pregnant women and individuals with weakened immune systems. It is important to take precautions to prevent infection and seek medical treatment if symptoms develop.

In the case of diagnostic testing, detection of C. trachomatis, N. gonorrhoeae and Trichomonas vaginalis should be done using a nucleic acid amplification test (NAAT) using first-void urine in men and, in women, a self-collected or healthcare-worker-collected vulvovaginal or endocervical swab. In some specific situations, collection of first-void urine may provide an alternative option to a vaginal swab; however, a vaginal swab is the preferred specimen as the yield is higher than with urine in women.

In the absence of diagnostic tests, syndromic treatment (i.e. empirical antimicrobial treatment that covers the most likely aetiology of the syndrome that the patient presents with) should be provided and patients instructed to return for further management if there is not resolution of symptoms.

Given the high burden of STIs in Southern Africa, the syndromic treatment regimen of VDS should cover C. trachomatis, N. gonorrhoeae and T. vaginalis infection in sexually active women. The recommended empirical regimen is azithromycin, ceftriaxone, and metronidazole.

The most appropriate treatment regime for a pregnant HIV positive woman with a Trichomonas vaginalis infection is metronidazole 500mg twice daily for 7 days. A 7-day course of metronidazole is preferred over single-dose treatment as it has a higher efficacy for the treatment of T. vaginalis and, if present, the added benefit of treating concurrent BV. However, single-dose metronidazole may be used in certain populations and settings based on the benefits of same-day and observed therapy, and medication availability.

It is important to treat both the pregnant woman and her sexual partners to prevent reinfection. Additionally, screening for other sexually transmitted infections should be carried out to ensure comprehensive care for the patient.

Pregnant adolescents are a unique population that requires special attention when it comes to ART and HIV management. Due to their age and stage in life, they may face additional challenges such as lack of access to healthcare, stigma, and difficulties in adhering to treatment regimens.

It is advised to prioritize their education over health interventions as this can have a long-term impact on their health outcomes. Adult treatment regimens may not be suitable for pregnant adolescents as their bodies are still developing and may require adjustments to the ART regimen.

A regular ART regimen may not be sufficient for pregnant adolescents, as they may need a tailored approach to maternal management and infant prophylaxis to ensure the health and well-being of both the mother and the baby.

Delaying ART initiation until after delivery is not recommended as it can increase the risk of mother-to-child transmission of HIV. It is important to start ART as soon as possible to reduce the viral load and protect the baby from HIV transmission.

In conclusion, pregnant adolescents should receive a tailored approach to their maternal management and infant prophylaxis to ensure the best possible outcomes for both the mother and the baby.

Congenital tuberculosis is a rare condition that occurs when a newborn is infected with tuberculosis bacteria while still in the womb. The baby may become infected if the mother has active tuberculosis during pregnancy.

The features of congenital tuberculosis typically include symptoms such as poor feeding, poor weight gain, cough, lethargy, irritability, fever, ear discharge, and skin lesions. Signs of congenital TB may include failure to thrive, icterus, hepatosplenomegaly, tachypnoea, and lymphadenopathy.

In the case of the newborn in the scenario provided, the features of congenital tuberculosis mentioned are all commonly associated with the condition, except for diarrhea. Diarrhea is not a typical symptom or sign of congenital tuberculosis.

The most probable diagnosis in this case is hereditary spherocytosis. This conclusion is based on the patient’s presentation of jaundice, fatigue, and abdominal pain, along with a history of chronic fatigue and previous episodes of hepatitis. The absence of fever and travel history to endemic areas makes acute hepatitis and cholecystitis less likely.

The blood results showing low hemoglobin levels, high MCV, high reticulocyte count, and elevated LDH also point towards a chronic hemolytic anemia. The negative Coombs test rules out autoimmune hemolytic anemia, leaving hereditary spherocytosis as the most likely cause.

Hereditary spherocytosis is a genetic disorder that causes red blood cells to be more fragile, leading to their destruction and resulting in anemia. Splenomegaly and gallstones are common complications of this condition due to increased red cell destruction and hemoglobin metabolism. Abdominal ultrasound showing an enlarged spleen further supports the diagnosis of hereditary spherocytosis.

The CD4 count is a measure of the number of CD4 T cells in a person’s blood, which are a type of white blood cell that plays a crucial role in the immune system. A CD4 count below 200/mcL is considered a significant threshold because it indicates severe immunosuppression and a weakened immune system.

When the CD4 count drops below 200/mcL, the risk of opportunistic infections significantly increases. Opportunistic infections are caused by pathogens that typically do not cause illness in individuals with a healthy immune system, but can take advantage of a weakened immune system to cause severe infections. These infections can be life-threatening in individuals with HIV/AIDS or other conditions that compromise the immune system.

Therefore, it is crucial for healthcare providers to closely monitor CD4 counts in individuals with HIV/AIDS and other immunocompromised conditions to assess the risk of opportunistic infections and provide appropriate treatment and preventive measures.

The guidelines outline the criteria for switching existing clients to DTG-containing regimens for those who have been on PI-based regimens for more than two years. The decision to switch is dependent on the client’s viral load in the last 12 months, and even clients who have failed a previous regimen are considered for switching to a DTG-containing regimen, regardless of their viral load, aiming to optimize their treatment.

Screening pregnant and postnatal women for depression and anxiety is crucial because these conditions can have a significant impact on both the mother and the baby. Depression and anxiety can affect a woman’s ability to care for herself and her child, as well as her overall well-being. By identifying women who may be at risk for these mental health issues, healthcare providers can offer appropriate support and interventions to help them cope and manage their symptoms. This can ultimately lead to better outcomes for both the mother and the baby, as well as improve the overall experience of pregnancy and childbirth. Therefore, the purpose of screening pregnant and postnatal women for depression and anxiety is to identify those who may need additional psychosocial support in order to promote their mental health and well-being.

Esophageal candidiasis is a fungal infection caused by Candida species, most commonly Candida albicans. Fluconazole is a preferred drug for the treatment of severe recurrent esophageal candidiasis due to its high efficacy and safety profile. It is a triazole antifungal medication that works by inhibiting the synthesis of ergosterol, a key component of the fungal cell membrane.

Nystatin is another antifungal medication that is commonly used for the treatment of oral candidiasis, but it is not as effective for esophageal candidiasis. Itraconazole is also effective for esophageal candidiasis, but fluconazole is generally preferred due to its better tolerability and ease of administration.

Amphotericin B is a polyene antifungal medication that is reserved for severe cases of esophageal candidiasis that are resistant to other antifungal drugs. Caspofungin is an echinocandin antifungal medication that is typically used for invasive fungal infections, but it may also be considered for the treatment of esophageal candidiasis in certain cases.

Epididymo-orchitis is probable in individuals with a low risk of sexually transmitted infections, such as a married man in his 50s who only has one sexual partner, and is most likely caused by enteric organisms like E. coli due to the presence of pain, swelling, and a history of urinary tract infections.

Epididymo-orchitis is a condition where the epididymis and/or testes become infected, leading to pain and swelling. It is commonly caused by infections spreading from the genital tract or bladder, with Chlamydia trachomatis and Neisseria gonorrhoeae being the usual culprits in sexually active younger adults, while E. coli is more commonly seen in older adults with a low-risk sexual history. Symptoms include unilateral testicular pain and swelling, with urethral discharge sometimes present. Testicular torsion, which can cause ischaemia of the testicle, is an important differential diagnosis and needs to be excluded urgently, especially in younger patients with severe pain and an acute onset.

Investigations are guided by the patient’s age, with sexually transmitted infections being assessed in younger adults and a mid-stream urine (MSU) being sent for microscopy and culture in older adults with a low-risk sexual history. Management guidelines from the British Association for Sexual Health and HIV (BASHH) recommend ceftriaxone 500 mg intramuscularly as a single dose, plus doxycycline 100 mg orally twice daily for 10-14 days if the organism causing the infection is unknown. Further investigations are recommended after treatment to rule out any underlying structural abnormalities.

When managing a client on antiretroviral therapy (ART) with a viral load ≥ 1000 c/mL after two years on a dolutegravir (DTG) or protease inhibitor (PI)-containing regimen, it is important to first assess the possible reasons for the unsuppressed viral load. One of the key factors to consider is the client’s adherence to their medication regimen.

If the client’s adherence is over 80%, it is recommended to focus on improving adherence before making any changes to the ART regimen. Resistance to dolutegravir is rare, so switching to a new regimen may not necessarily address the issue of unsuppressed viral load. By identifying and addressing the root causes of non-adherence, such as side effects, pill burden, or psychosocial factors, the client may be able to achieve viral suppression while remaining on their current regimen.

Therefore, the recommended approach in this scenario would be to focus on improving adherence before considering any changes to the ART regimen. This approach prioritizes the client’s well-being and aims to achieve viral suppression in the most effective and sustainable way possible.

Hepatitis B surface antigen (HBsAg) is a protein on the surface of the hepatitis B virus, that is the first serologic marker to appear in a new acute infection.It can be detected as early as 1 week and as late as 9 weeks. It can be detected in high levels in serum during acute or chronic hepatitis B virus infection. The presence of HBsAg indicates that the person is infectious. The body normally produces antibodies to HBsAg as part of the normal immune response to infection. HBsAg is the antigen used to make hepatitis B vaccine.
Hepatitis B surface antibody (anti-HBs) indicates recovery and immunity from the hepatitis B virus infection. Anti-HBs also develops in a person who has been successfully vaccinated against hepatitis B.
Total hepatitis B core antibody (anti-HBc): Appears at the onset of symptoms in acute hepatitis B and persists for life. The presence of anti-HBc indicates previous or ongoing infection with hepatitis B virus in an undefined time frame. It is not present following hepatitis B vaccination.
IgM antibody to hepatitis B core antigen (IgM anti-HBc) indicates recent infection with hepatitis B virus (<6 months). Its presence indicates acute infection.
The following table summarises the presence of hepatitis B markers according to each situation:
Susceptible to infection:
HBsAg = Negative
Anti-HBc = Negative
Anti-HBs = Negative

Immune due to natural infection:
HBsAg = Negative
Anti-HBc = Positive
Anti-HBs = Positive

Immune due to vaccination:
HBsAg = Negative
Anti-HBc = Negative
Anti-HBs = Positive

Acute infection:
HBsAg = Positive
Anti-HBc = Positive
Anti-HBs = Negative
IgM anti-HBc = Positive

Chronic infection:
HBsAg = Positive
Anti-HBc = Positive
Anti-HBs = Negative
IgM anti-HBc = Negative

Hepatitis C virus (HCV) can be transmitted from mother to baby during pregnancy and childbirth, although the risk is relatively low compared to other bloodborne viruses like HIV. Fetal scalp blood sampling is an invasive procedure that can increase the risk of vertical transmission of HCV, especially if the mother has a high viral load at the time of delivery. Therefore, it is recommended to avoid this procedure in pregnant women with HCV.

Caesarean section has not been shown to significantly reduce the risk of HCV transmission from mother to baby, so it is not considered a preventive measure in this case. However, the baby should be screened for hepatitis C shortly after delivery to determine if transmission has occurred.

The co-existence of HIV can increase the risk of HCV transmission, so it is important for the pregnant woman to be tested for HIV as well. Breastfeeding is generally considered safe for women with HCV, as long as there are no cracks or bleeding in the nipples that could potentially expose the baby to infected blood.

In conclusion, fetal scalp blood sampling should be avoided in pregnant women with HCV to reduce the risk of vertical transmission to the baby. Other measures such as screening the baby after delivery and testing for HIV should also be taken to ensure the health of both the mother and the baby.

When a woman on antiretroviral therapy (ART) has an unsuppressed viral load (>50 c/ml), it is important to take action to ensure that the treatment is effective in controlling the HIV virus. The recommended action of repeating the viral load testing in 4-6 weeks allows healthcare providers to monitor the viral load levels over time and determine if the current treatment regimen is working effectively.

By repeating the viral load testing in a relatively short period of time, healthcare providers can assess if the unsuppressed viral load was a temporary blip or if it is a consistent issue that requires a change in treatment. This approach allows for timely intervention and adjustment of the treatment plan if necessary to ensure that the woman’s HIV is well-controlled and to prevent the development of drug resistance.

Switching to a second-line or third-line regimen may be considered if the viral load remains unsuppressed after repeat testing, as this indicates that the current treatment is not effectively suppressing the virus. However, this decision should be made in consultation with a healthcare provider based on the individual’s specific circumstances and treatment history.